2003
DOI: 10.1016/s0306-4522(02)00958-2
|View full text |Cite
|
Sign up to set email alerts
|

Glial cell line-derived neurotrophic factor contributes to delayed inflammatory hyperalgesia in adjuvant rat pain model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
29
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(32 citation statements)
references
References 54 publications
3
29
0
Order By: Relevance
“…However, it should be noted that a 15 d intrathecal application of high concentrations (12 g/d) of GDNF caused a reduction in neuropathic pain after peripheral nerve injury (Boucher et al, 2000). Conversely, injection of an antibody to GDNF decreased hyperalgesia after complete Freund's adjuvant injection (Fang et al, 2003). Clearly, the route of administration and experimental model are critical factors in the evaluation of GDNF action in the sensory system.…”
Section: Discussionmentioning
confidence: 99%
“…However, it should be noted that a 15 d intrathecal application of high concentrations (12 g/d) of GDNF caused a reduction in neuropathic pain after peripheral nerve injury (Boucher et al, 2000). Conversely, injection of an antibody to GDNF decreased hyperalgesia after complete Freund's adjuvant injection (Fang et al, 2003). Clearly, the route of administration and experimental model are critical factors in the evaluation of GDNF action in the sensory system.…”
Section: Discussionmentioning
confidence: 99%
“…To ensure that this effect at 24 hours on the contralateral paw was not due to the trauma of IA injection, tests were performed on mice in which 10 l saline had been injected IA into one knee joint and the other joint left untreated. At 24 hours, neither hind paw exhibited a change in thermal hyperalgesic threshold (data not shown), thus suggesting that the observed change seen in the contralateral paw at 24 hours may have been due to bilateral hyperalgesia (23)(24)(25). Throughout the time course, the TRPV1 Ϫ/Ϫ mice exhibited no change in thermal hyperalgesic thresholds from baseline levels, whereas it was not until 2 weeks that the threshold returned to normal in the paws of the CFA-treated WT mice ( Figure 5).…”
Section: Trpv1 In Joint Inflammationmentioning
confidence: 96%
“…Thus, neurotrophic factors can enhance axonal growth in different models of SCI, and each one may play a distinct role in modulating neural function with certain redundancy. Nonetheless, eventual clinical application of neurotrophic factors may encounter limitations because of side effects such as hyperalgesia associated with NGF [95].…”
Section: Strategy 4: Application Of Neurotrophic Factors and Viral Vementioning
confidence: 99%